Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:JNJ
DateTimeSourceHeadlineSymbolCompany
12/02/20224:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
12/01/20226:01AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:JNJJohnson and Johnson
11/30/20225:50PMDow Jones NewsJohnson & Johnson CEO Joaquin Duato to Become Chairman of the BoardNYSE:JNJJohnson and Johnson
11/30/20225:00PMBusiness WireJohnson & Johnson Names CEO Joaquin Duato as Chairman of the BoardNYSE:JNJJohnson and Johnson
11/15/20227:30AMGlobeNewswire Inc.Purpose Investments Files Preliminary Prospectus for the First Yield-Focused Single-Stock ETFsNYSE:JNJJohnson and Johnson
11/11/202211:31AMDow Jones NewsJohnson & Johnson On Track for Largest Percent Decrease Since June 2020 -- Data TalkNYSE:JNJJohnson and Johnson
11/10/20224:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
11/10/20224:45PMEdgar (US Regulatory)Form 13f Holdings Report (13f-hr)NYSE:JNJJohnson and Johnson
11/09/20225:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
11/04/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
11/01/20222:19PMDow Jones NewsTrending: Johnson & Johnson to Buy AbiomedNYSE:JNJJohnson and Johnson
11/01/202211:45AMDow Jones NewsSonnet BioTherapeutics Shares Jump 36% After Janssen CollaborationNYSE:JNJJohnson and Johnson
11/01/20227:35AMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NYSE:JNJJohnson and Johnson
11/01/20226:30AMBusiness WireJohnson & Johnson to Acquire AbiomedNYSE:JNJJohnson and Johnson
10/31/20227:13PMDow Jones NewsSonnet BioTherapeutics Up 66% in Regular Session on Collaboration With JanssenNYSE:JNJJohnson and Johnson
10/31/20228:36AMDow Jones NewsEssa Pharma Shares Drop 26% After Janssen Suspends Enrollment for TrialsNYSE:JNJJohnson and Johnson
10/27/20222:06AMTipRanksSVB Securities Sticks to Its Buy Rating for Johnson & Johnson (JNJ)NYSE:JNJJohnson and Johnson
10/26/20227:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/26/20227:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/26/20227:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/26/20227:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/26/20227:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/26/20224:48PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:JNJJohnson and Johnson
10/26/20228:52AMDow Jones NewsLigand Pharmaceuticals Partner Janssen Biotech Gets FDA Approval for TecvayliNYSE:JNJJohnson and Johnson
10/21/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/21/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/21/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/21/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:JNJJohnson and Johnson
10/20/20229:15PMTipRanksCredit Suisse Reaffirms Their Hold Rating on Johnson & Johnson (JNJ)NYSE:JNJJohnson and Johnson
10/19/20228:35AMTipRanksAtlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ)NYSE:JNJJohnson and Johnson
 Showing the most relevant articles for your search:NYSE:JNJ

Your Recent History

Delayed Upgrade Clock